BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33720741)

  • 21. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2019 May; 17(5):345-351. PubMed ID: 31092056
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypomagnesemia and proton pump inhibitors].
    Fumeaux C; Schmidtko J; Meier P
    Rev Med Suisse; 2012 Apr; 8(336):806-10. PubMed ID: 22574415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.
    Perrier M; Delemer B; Deguelte S; Legros V; Brixi H; Kianmanesh R; Cadiot G
    Pancreatology; 2021 Jan; 21(1):236-239. PubMed ID: 33309626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse event profiles of hypomagnesemia caused by proton pump inhibitors using the Japanese Adverse Drug Event Report (JADER) Database.
    Yamashiro K; Hosomi K; Yokoyama S; Ogata F; Nakamura T; Kawasaki N
    Pharmazie; 2022 Sep; 77(7):243-247. PubMed ID: 36199184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors.
    Janett S; Bianchetti MG; Milani GP; Lava SA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):e39. PubMed ID: 27010402
    [No Abstract]   [Full Text] [Related]  

  • 32. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
    Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
    Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypomagnesemia.
    Ayuk J; Gittoes NJ
    Am J Kidney Dis; 2014 Apr; 63(4):691-5. PubMed ID: 24100128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
    Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
    Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy.
    Cabras P; Anedda M; Caddeo L; Francesco M; Antonella M
    Am J Ther; 2020; 27(6):e676-e680. PubMed ID: 31425160
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 40. Lansoprazole-induced hypomagnesaemia.
    Krupa LZ; Fellows IW
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24414180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.